Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of intravenous-to-oral solithromycin versus moxifloxacin for community-acquired bacterial pneumonia
2013-003453-13Phase 3Completed
- Sponsor
- Cempra
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in community acquired pneumonia (CAP) comparing IV-to-oral solithromycin with IV-to-oral moxifloxacin (2 arms). Started Apr 2014; status: completed.
02
Drugs
solithromycinmoxifloxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2013-003453-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003453-13.